Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1991 3
1992 2
1993 6
1994 3
1995 1
1996 3
1997 2
1999 1
2003 3
2004 2
2005 8
2006 4
2007 6
2008 9
2009 7
2010 8
2011 11
2012 3
2013 8
2014 14
2015 8
2016 6
2017 6
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies
Sanyal AJ, et al. Aliment Pharmacol Ther 2017. Among authors: Rossaro L. PMID 28370090 Free PMC article.
METHODS: Pooled patient-level data from two large phase 3, randomised, placebo-controlled studies were analysed for HRS reversal [serum creatinine (SCr) value ≤133 μmol/L], 90-day survival, need for renal replacement therapy and predictors of HRS reversal. ...Terlipressin was associated with a more significant improvement in renal function from baseline until end of treatment, with a mean between-group difference in SCr concentration of -53.0 μmol/L (P < 0.0001). ...
METHODS: Pooled patient-level data from two large phase 3, randomised, placebo-controlled studies were analysed for HRS reversal [serum crea …
115 results
Jump to page
Feedback